ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Clinical trials verification of "Cinepazide Maleate Injection (Kelinao)" completed to treat Acute Ischemic Stroke
June 05, 2019Product has obtained post-launch verification promising prognosis of stroke patients, lower disability rate and improve cerebral circulation -
3K3A-APC demonstrates safety in clinical trial for acute ischemic stroke
February 28, 2018A preliminary Phase 2 clinical trial has demonstrated that patients with acute ischemic stroke, can safely tolerate high doses of 3K3A-APC, a promising anti-stroke drug… -
Enrollment of first human subject for Lumosa Therapeutics’ LT3001 trial
August 15, 2017The first human subject was dosed with LT3001 in California, USA on 28 July 2017, with the trial to evaluate the safety and pharmacokinetics of LT3001 expected to be completed in early 2018.
Pharma Sources Insight January 2025
